Biotech Capital (ASX:BTC) announced yesterday it will commence trading as BTC Health, remaining a listed company on the ASX and registered as a Pooled Development Fund.
BTC Health provides development capital and management expertise to high-growth Australian biotech, medtech and pharmaceutical companies on behalf of a strong shareholder base from its Melbourne head office.
The company’s strategy is to make active investments in life science businesses and late-stage product development opportunities that will benefit from greater access to development capital.
The company says it has the longer-term objective of building a group of “complementary businesses that are entrepreneurial, innovative, globally focused and when operating together have the ability to generate better health outcomes and value for its shareholders.”
With an experienced Board under the Executive Chairmanship of Richard Treagus, and including a number of experienced biotech identities, the company says it is well placed to execute on range of strategic investments in the life sciences sector.